Stay updated on Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.5 to v3.6.6, reflecting a metadata update to the study record history. This indicates an update to the page's versioning rather than new study information.
    Difference
    0.1%
    Check dated 2026-08-29T19:42:49.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The record history now shows a new revision label (v3.6.5), indicating an update to the study record.
    Difference
    0.1%
    Check dated 2026-08-08T16:13:23.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry 'Revision: v3.6.4', replacing the previous 'Revision: v3.6.3'. This indicates a page update to the ClinicalTrials.gov study record.
    Difference
    0.1%
    Check dated 2026-07-25T06:42:16.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The study record history is updated with a new revision entry for v3.6.3. The previous v3.6.2 entry is removed from the visible history.
    Difference
    0.1%
    Check dated 2026-07-03T20:52:41.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The revision label on the history page was updated from v3.6.0 to v3.6.2, reflecting a new software release.
    Difference
    0.1%
    Check dated 2026-06-26T20:04:30.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    The page adds a 'Check who can join' option and a 'Find Contact Information' link, and the release notes show a new Revision: v3.6.0, replacing v3.5.5.
    Difference
    0.6%
    Check dated 2026-06-12T12:24:21.000Z thumbnail image

Stay in the know with updates to Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.